Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (53 ops.)
Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €4.3M.
Filing timeline
BuySaleStephen F. Betz
Insider track record
Disclosed buys
0
Disclosed sells
53
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen F. Betz: trading record in brief
Stephen F. Betz is a declared insider of Crinetics Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 67 filings; the first trade dates from 21 October 2021 and the latest from 1 September 2026.
No open-market purchase appears, only 53 sales worth €7.8M. Other entries cover 7 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 1 September 2026 with a transaction (€4.3M) in Crinetics Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen F. Betz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
58,286 shares@ US$85.000.055% mcap28.4% of flowCommon StockSEC:0001628280-26-059884:0
79,650 shares@ US$85.000.075% mcap38.8% of flowCommon StockSEC:0001628280-26-059884:1
6,371 shares@ US$37.114.2% of flowCommon StockSEC:0001628280-26-019498:0
30,000 shares0Common StockSEC:0001628280-26-011718:0
18,000 shares@ US$1.910.6% of flowCommon StockSEC:0001628280-25-059009:0
71,525 shares@ US$1.912.5% of flowCommon StockSEC:0000950170-25-086804:0
5,479 shares@ US$34.172.9% of flowCommon StockSEC:0000950170-25-043402:0
43,000 shares0Common StockSEC:0000950170-25-025664:0
2,331 shares@ US$1.910.1% of flowCommon StockSEC:0000950170-24-137923:0
1,035 shares@ US$51.500.8% of flowCommon StockSEC:0000950170-24-105952:0
3,000 shares@ US$53.192.4% of flowCommon StockSEC:0000950170-24-101434:0
3,000 shares@ US$47.682.2% of flowCommon StockSEC:0000950170-24-097085:0
3,000 shares@ US$53.432.5% of flowCommon StockSEC:0000950170-24-086935:0
3,000 shares@ US$48.552.3% of flowCommon StockSEC:0000950170-24-083221:0
3,000 shares@ US$45.372.2% of flowCommon StockSEC:0000950170-24-077905:0
3,000 shares@ US$43.862.1% of flowCommon StockSEC:0000950170-24-071971:0
3,000 shares@ US$47.492.2% of flowCommon StockSEC:0000950170-24-066657:0
3,000 shares@ US$49.432.3% of flowCommon StockSEC:0000950170-24-059865:0
3,655 shares@ US$38.142.2% of flowCommon StockSEC:0001209191-24-005010:0
23,000 shares0Common StockSEC:0001209191-24-004604:0
3,000 shares@ US$37.261.8% of flowCommon StockSEC:0001209191-24-002314:0
3,000 shares@ US$37.651.8% of flowCommon StockSEC:0001209191-24-001510:0
3,000 shares@ US$35.891.7% of flowCommon StockSEC:0001209191-23-059809:0
3,000 shares@ US$32.871.6% of flowCommon StockSEC:0001209191-23-058503:0
3,000 shares@ US$31.841.5% of flowCommon StockSEC:0001209191-23-056904:0
25 of 58 declarations
